Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
Several proteins modify the biological response to lipopolysaccharide (LPS). Both bactericidal/permeability-increasing factor (BPI), a protein stored in neutrophils, and the acute phase protein LPS-binding protein (LBP) bind to LPS; however, BPI inhibits while LBP enhances binding of LPS to leukocytes and subsequent induction of cytokines. We investigated plasma levels of BPI, LBP, elastase and C5a before, during and after hemodialysis (HD). Six patients were dialysed with Cuprophane (Cup) and polysulfone (PS) low-flux dialyzers on two consecutive HD sessions. There was a significant, 10.9 +/- 2.8-fold increase in BPI after 4-hour HD compared to predialysis and a 4.4 +/- 1.6-fold increase in elastase after 4-hour HD using Cup. Plasma levels of BPI and elastase decreased rapidly after the dialysis session. HD with PS resulted in a smaller, but still significant rise in BPI (3.7 +/- 1.6-fold at 4 hours) and elastase (1.69 +/- 0.2-fold at 4 hours). Levels for BPI and elastase were similar in the arterial and venous blood lines of the dialyzer. Plasma levels of LBP did not change during or after the HD session. These data indicate that BPI, but not LBP is released during HD with Cup and to a lesser extent with PS. Activation of neutrophils and release of BPI during HD may influence the biological response to bacterial products possibly introduced during HD.
Schindler
R
R
Department of Nephrology, Medical School Hannover, Germany.
Marra
M N
MN
McKelligon
B M
BM
Lonnemann
G
G
Schulzeck
P
P
Schulze
M
M
Oppermann
M
M
Shaldon
S
S
D000209:Acute-Phase Proteins / Q000032:analysis*; D023181:Antimicrobial Cationic Peptides; D001770:Blood Bactericidal Activity; D001798:Blood Proteins / Q000032:analysis*; D002352:Carrier Proteins / Q000097:blood*; D002482:Cellulose / Q000031:analogs & derivatives; D015936:Complement C5a / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007118:Immunoassay; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D008567:Membranes, Artificial; D010196:Pancreatic Elastase / Q000097:blood; D011108:Polymers; D006435:Renal Dialysis; D013450:Sulfones; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D002352:Carrier Proteins; D002482:Cellulose; D015936:Complement C5a; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D008567:Membranes, Artificial; D010196:Pancreatic Elastase; D011108:Polymers; D013450:Sulfones; D000099231:Lipopolysaccharide-Binding Protein; C021623:bactericidal permeability increasing protein; C017662:polysulfone P 1700; C009865:cuprammonium cellulose